Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Capital Expenditures (2017 - 2026)

Kodiak Sciences' (KOD) quarterly Capital Expenditures came in at $942000.0 in Q1 2026, up 248.89% YoY from $270000.0 in Q1 2025, and up 2090.7% on a QoQ basis from $43000.0 in Q4 2025.

Analysis

Kodiak Sciences (KOD) Capital Expenditures (2017 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Capital Expenditures data on file, last reported at $942000.0 in Q1 2026.

  • Quarterly Capital Expenditures rose 248.89% year-over-year to $942000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 89.09% YoY) and the FY2025 annual result came in at $506000.0, up 34.93% from the prior year.
  • Capital Expenditures improved to $942000.0 in Q1 2026, from $43000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $27.5 million in Q4 2023 to a low of $22000.0 in Q1 2024.
  • A 5-year average of $4.7 million and a median of $270000.0 in 2025 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2022 — Capital Expenditures soared 1311.48% — and 2024, when it sank 99.82%.
  • Tracing KOD's Capital Expenditures over 5 years: stood at $3.1 million in 2022, then soared by 797.29% to $27.5 million in 2023, then plunged by 99.55% to $124000.0 in 2024, then plunged by 65.32% to $43000.0 in 2025, then soared by 2090.7% to $942000.0 in 2026.
  • The last three Capital Expenditures figures came in at $942000.0 (Q1 2026), $43000.0 (Q4 2025), and $60000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn - 352,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 352,000.00
Mar 31, 2026 942,000.00
Dec 31, 2025 43,000.00
Sep 30, 2025 60,000.00
Jun 30, 2025 133,000.00
Mar 31, 2025 270,000.00
Dec 31, 2024 124,000.00
Sep 30, 2024 180,000.00
Jun 30, 2024 49,000.00
Mar 31, 2024 22,000.00
Dec 31, 2023 27.48 Mn
Sep 30, 2023 226,000.00
Jun 30, 2023 1.47 Mn
Mar 31, 2023 12.17 Mn
Dec 31, 2022 3.06 Mn
Sep 30, 2022 8.27 Mn
Jun 30, 2022 8.23 Mn
Mar 31, 2022 17.46 Mn
Dec 31, 2021 8.43 Mn
Sep 30, 2021 4.83 Mn